GALECTIN THERAPEUTICS INC. Public Float
GALECTIN THERAPEUTICS INC. (GALT) had Public Float of $109.00 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $109.00M.
- 2024-06-30: Entity Public Float $112.00M.
- 2023-06-30: Entity Public Float $63.00M.
- 2022-06-30: Entity Public Float $59.00M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $109.00M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $112.00M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $63.00M 10-K · filed 2024-03-29 | |
| 2022-06-30 | $59.00M 10-K · filed 2023-03-30 | |
| 2021-06-30 | $139.00M 10-K · filed 2022-03-31 | |
| 2020-06-30 | $126.00M 10-K · filed 2021-03-31 | |
| 2019-06-30 | $166.00M 10-K · filed 2020-03-16 | |
| 2018-06-30 | $213.00M 10-K · filed 2019-03-06 | |
| 2017-06-30 | $67.00M 10-K · filed 2018-03-29 | |
| 2015-06-30 | $35.60M 10-K · filed 2017-03-28 | $52.70M 10-K · filed 2016-03-15 |
| 2014-06-30 | $245.70M 10-K · filed 2015-03-18 | |
| 2013-06-30 | $55.40M 10-K · filed 2014-03-21 | |
| 2012-06-30 | $29.90M 10-K · filed 2013-03-29 | |
| 2011-06-30 | $73.70M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |